Lighter You Tirzepatide Review: $339 in the Store, $169 in the Ads (2026)

Lighter You sells compounded tirzepatide at $339 per four weeks. That figure is in its store and again inside its intake, and the two agree. It is also almost exactly twice the number its own marketing pages advertise for the same product — "Starting at $169/mo Tirzepatide Injection" — which is still live on the same brand.

⚠ A correction to this page. When we first read Lighter You in August 2026 we concluded it published no tirzepatide price at all, and we said so in the headline. That was wrong, and it was wrong in the way absence claims usually are: we read a homepage and a login-gated button and treated the silence as a fact about the company. The store was the surface that mattered, and it prices the drug openly. This page has been rewritten around what a buyer actually pays.

The two price surfaces, and which one takes your money

The marketing pages sell floors. The store sells products, and the store is where the card is charged. On 1 September the gap between them was not a rounding difference: $169 advertised against $339 charged for the tirzepatide injection, and $96 advertised against $179 charged for every microdose SKU. A third surface, the peptide page, prices the same non-GLP-1 products differently again from the store.

We are being precise about this: neither figure is invented, and the $169 is not a bait price for a product that does not exist. It is a "starting at" line that has stopped tracking the catalog beneath it. But a reader planning a year of treatment on $169 a month is planning on roughly half the real number, and the real number is not billed monthly either.

The month is four weeks

The store does not say "per month". It says per 4 week, and so does the intake. That is thirteen charges in a calendar year rather than twelve, so $339 per four weeks is $4,407 a year and not the $4,068 that "$339 a month" implies. The marketing pages, meanwhile, write their floors with "/mo". The cadence and the figure come from two different surfaces, and only one of them is the one you are billed on.

The figure we file for Lighter You in our tirzepatide price index is $339 per four weeks — the transactable one, taken from the two surfaces that agree with each other and take payment, not from the advertisement.

What it actually is, which is not nothing

A company whose advertisement and whose checkout disagree by a factor of two invites the word shell, and it is worth saying clearly that this is not one. Lighter You does several things that most of the companies we review will not:

• •It names four pharmacies, with street addresses. Red Rock Home Pharmacy in St. George, Utah; Health Warehouse in Florence, Kentucky; Precision Compounding Pharmacy in Bellmore, New York; and Triad Rx in Daphne, Alabama. Each of Auren Rx, Pepti and Rehydra+ Wellness names one; naming four, with addresses, is a longer answer than this category usually gives.
• •Its telehealth consent is hosted by OpenLoop, an established clinical-infrastructure company, which means there is a real prescribing layer rather than a form and a hope.
• •Its certification badge is served from the certifier's own image host rather than being a self-hosted graphic. ⚠ That is worth exactly what it says and no more: it shows the identifier was issued to somebody, and it establishes nothing about who holds the certification. We do not treat it as proof that Lighter You is certified, and neither should you.
• •It ships complete legal documents: terms, privacy, a HIPAA notice and a refund policy.

So the problem here is not legitimacy. It is that a legitimate company is running two price surfaces that disagree, and only warns you about it by charging you.

Two companies, one website

The terms of service and the privacy policy name the operator as Lighter You, LLC. The HIPAA notice of privacy practices names it as Lighter You Health, Inc. Those are different legal entities in different corporate forms, named as the operator across four legal documents on one site, and neither has a published address. If you ever needed to know who your agreement is with — for a refund, a records request or a complaint — the site gives you two answers.

The refund policy contradicts the FAQ, in capitals

The homepage FAQ promises a 30-day satisfaction guarantee. The refund policy says the opposite, and says it in block capitals: other than cancellation for medical disqualification, in no event shall you be issued a refund on cancellation of the subscription. Refunds, where they are issued at all, cover only the most recent billing cycle, and cancellation requires 72 hours' notice.

Where two documents on one site disagree, the policy governs and the marketing does not — that is the same rule we applied to Pepti's payment timing. Assume no satisfaction guarantee exists.

You are also charged for your first month when you submit the intake form, before a provider has reviewed you, with a refund only if you are medically disqualified. So the sequence is: pay an unpublished amount, then be assessed.

The regulatory screen

The brand name, and all four named pharmacies, returned zero company-column matches in the FDA's live warning-letter index in August 2026.² The nearest hit for the brand string was a tobacco letter to an unrelated company with a similar name — not this business. The screen carried a positive control that correctly surfaced a real February 2026 letter to a telehealth seller on every pass,³ so the zeroes are evidence. Lighter You has no FDA warning letter, and neither does any pharmacy it names.

If you are here for tirzepatide

What the store sells is compounded tirzepatide, not brand Zepbound, and the store states the product and the four-week cycle. What it does not state is the dose behind the figure, or whether $339 holds as you titrate up — and no page on the site answers that. That is the first question our guide to choosing a provider online tells you to ask. The compounded distinction is not academic — compounded tirzepatide is not an FDA-approved finished drug and was not the product studied in the trials that make the molecule worth taking (see is compounded tirzepatide still legal in 2026), and the trial results themselves — about 15% to 21% average body-weight loss over 72 weeks in SURMOUNT-1⁴, about 20% versus 14% against semaglutide in SURMOUNT-5⁵ — belong to the brand product. Our tirzepatide evidence guide has the rest.

The honest verdict

Lighter You is a real operator with a genuine clinical partner and four named dispensing pharmacies, and it does publish a tirzepatide price — we were wrong about that in August and have said so above. What it has not fixed is the gap between the price it advertises and the price it charges: $169 a month in the marketing, $339 per four weeks at the till, with the microdose line off by a similar multiple. Add a card charged when the intake is submitted rather than after a clinician has read it, a satisfaction guarantee its own refund policy denies in capital letters, two legal entities named as the operator, and no 503A or 503B designation for any of the four pharmacies, and the shape of the caution is clear: read the store, not the banner, and read it again at your next dose. Trellis Vitality at $199 a month and The Edit at $349 publish ladders whose figures match at both ends, and the rest of the field is ranked on our best tirzepatide providers ranking.